In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 2: Risk Factors and Prevention - Secondary Prevention
Session

Congress : EuroPrevent 2019

Topic : Other

  • Session type : Poster Session
  • Date : 12 April 2019
  • Time : 08:30 - 18:00

29 presentations in this session

Application for cardiac self-Improvement(ANSIM), a randomized controlled trial: 9-month clinical outcome

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : JB Kim (Bucheon,KR)

A randomized trial of an exercise maintenance intervention after cardiac rehabilitation

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : R Reid (Ottawa,CA)

Effects of a community-based lifestyle intervention in older patients with coronary artery disease: results from the RESPONSE-2 trial

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : P Jepma (Amsterdam,NL)

Admission cardiac troponin T improves risk stratification of patients with ST elevation myocardial infarction

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : JA Coelho Lima Junior (Newcastle Upon Tyne,GB)

Current state of cardiovascular secondary prevention in patients with stable coronary heart disease: the Czech EUROASPIRE V Study.

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : J Bruthans (Praha 4,CZ)

Attainment of LDL cholesterol levels in an ambulatory high risk population: tendencies through 2013-2018 and clinical predictors.

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : E Rodenas Alesina (Barcelona,ES)

Multimorbidity, outcomes and preventive pharmacotherapy in patients with history of stroke: data of outpatient registry REGION

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : M Lukiyanov (Moscow,RU)

Cardiovascular risk factors modification and progression of coronary atherosclerosis in patients with coronary artery disease

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : K Averchenko (Saint-Petersburg,RU)

Attainment of LDL-C target and cardiovascular outcomes a year after an acute coronary syndrome

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : D Kosmidis (Thessaloniki,GR)

Secondary prevention target achievement after myocardial infarction among women and men with and without diabetes: a population-based study

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : L Hopstock (Tromso,NO)

Clinical and anthropometric predictors of body fat improvement after cardiac rehabilitation participation: a cross-sectional study

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : I Barillas (Guatemala,GT)

Awareness about target levels of cardiovascular risk factors in different types of hospitalized medical patients

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : N Pogosova (Moscow,RU)

What is the main barrier to reach LDL target levels in patients with coronary artery disease?

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : A Velez Salas (Madrid,ES)

Factors leading to poor adherence to secondar prophylaxis of rheumatic fever.

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : R Awan (Karachi,PK)

Are we paying adequate attention to HDL cholesterol?

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : A Velez Salas (Madrid,ES)

Cardiac rehabilitation and patient facilitated approach helps monitoring lipid management in very high risk cardiovascular disease patients

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : SMY Choo (Gateshead,GB)

Long-term management of cardiovascular risk factors in patients included in a cardiac rehabilitation unit

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : C Rus Mansilla (Andujar,ES)

Influence of patient adherence to healthy lifestyle in long-term cardiovascular events

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : C Rus Mansilla (Andujar,ES)

Premature cardiovascular diseases and comorbidity in outpatient and hospital practice: data of registries RECVASA and RECVASA-CLINICA

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : E Andreenko (Moscow,RU)

Statin therapy in patients with atherosclerotic cardiovascular disease: is our population under dosed?

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : M Faisal (Karachi,PK)

The prevalence of anxiety among patients with implantable cardioverter defibrillator in single and multicenter studies

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : R Olszewski (Warszawa,PL)

Relationship between cognitive impairment, left ventricle filling pressure and diastolic dysfunction in CAD patients

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : M Dolzhenko (Kiev,UA)

Dysphagia after cardiac surgery, are we underestimating it?

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : S Garcia de las Penas (Madrid,ES)

Effectiveness of treatment and risk factor modification in elderly and senile patients with coronary artery disease before myocardial revascularization

Congress : EuroPrevent 2019

  • Session : Risk Factors and Prevention - Secondary Prevention
  • Speaker : E Lubinskaya (Saint-Peterburg,RU)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are